;The binding agent can be a binding protein, an antibody, or an aptamer, and the analyte can be a biomolecule. Accordingly, the current invention provides a method of detecting the presence or assessing the likelihood of development of a disease associated with an abnormal level of a biomolecule in a subject."/>
公开/公告号US10309921B2
专利类型
公开/公告日2019-06-04
原文格式PDF
申请/专利号US201514636758
申请日2015-03-03
分类号G01N33/543;G01N27/327;
国家 US
入库时间 2022-08-21 12:12:32